The World Health Organisation (WHO), has granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.
Union Health Minister Mansukh Mandaviya on Tuesday said that approval for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin will be given on the basis of the meeting which will be convened by the World Health Organization (WHO) today.
The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech's submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.
Brazil’s federal prosecutor’s office is investigating possible irregularities in a Health Ministry contract to purchase 20 million doses of the Covaxin vaccine
As many as 50 employees of Bharat Biotech, an Indian COVID-19 manufacturing company, tested positive for the virus, a senior executive confirmed on Thursday.
Since India opened vaccinations to all adults this month the pace of administering the shots has dropped with states saying they only have limited stock to give out.
India opened vaccinations to all adults Saturday, launching a huge inoculation effort that was sure to tax the limits of the federal government, the country’s vaccine factories, and the patience of its 1.4 billion people.
India said on Tuesday that it will approve the use of all coronavirus vaccines that have been given an emergency nod by the World Health Organisation or regulators in the United States, Europe, Britain or Japan.
